Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Epidemiology ; 23(5): 677-85, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22627901

ABSTRACT

BACKGROUND: Major depressive disorder and the use of serotonin reuptake inhibitors (SRIs) in pregnancy have been associated with preterm birth. Studies that have attempted to separate effects of illness from treatment have been inconclusive. We sought to explore the separate effects of SRI use and major depressive episodes in pregnancy on risk of preterm birth. METHODS: We conducted a prospective cohort study of 2793 pregnant women, oversampled for a recent episode of major depression or use of an SRI. We extracted data on birth outcomes from hospital charts and used binary logistic regression to model preterm birth (<37 weeks' gestation). We used ordered logistic regression to model early (<34 weeks' gestation) or late (34-36 weeks) preterm birth, and we used nominal logistic regression to model preterm birth antecedents (spontaneous preterm labor/preterm premature rupture of membranes/preterm for medical indications/term). RESULTS: Use of an SRI, both with (odds ratio = 2.1 [95% confidence interval = 1.0-4.6]) and without (1.6 [1.0-2.5]) a major depressive episode, was associated with preterm birth. A major depressive episode without SRI use (1.2 [0.68-2.1]) had no clear effect on preterm birth risk. None of these exposures was associated with early preterm birth. Use of SRIs in pregnancy was associated with increases in spontaneous but not medically indicated preterm birth. CONCLUSIONS: SRI use increased risk of preterm birth. Although the effect of a major depressive episode alone was unclear, symptomatic women undergoing antidepressant treatment had elevated risk.


Subject(s)
Antidepressive Agents, Second-Generation/adverse effects , Depressive Disorder, Major/complications , Premature Birth/etiology , Selective Serotonin Reuptake Inhibitors/adverse effects , Adolescent , Adult , Antidepressive Agents, Second-Generation/therapeutic use , Depressive Disorder, Major/drug therapy , Female , Follow-Up Studies , Humans , Interviews as Topic , Logistic Models , Odds Ratio , Pregnancy , Pregnancy Complications/drug therapy , Prospective Studies , Risk Factors , Selective Serotonin Reuptake Inhibitors/therapeutic use , Young Adult
2.
Arch Gynecol Obstet ; 280(2): 333-5, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19184073

ABSTRACT

BACKGROUND: Tuberculosis is still a common problem in immigrant population with peritoneal tuberculosis as the most common presentation of extrapulmonary disease. CASE: A 36-year-old woman presented with abdominal distention, night sweats and weight loss. Physical examination and radiologic studies revealed ascites, omental caking and bilateral enlarged ovaries with an elevated serum Ca-125 of 353 U/mL. Acid-fast stain and culture were negative for Mycobacterium tuberculosis. Diagnostic laparoscopy and biopsy revealed multiple granulomas with epithelioid cells and caseification necrosis confirming tuberculosis. Treatment with anti-tuberculin drugs resulted in resolution of symptoms with a reduction in Ca-125 to normal. CONCLUSION: Laparoscopic biopsy with frozen section evaluation would spare patients with peritoneal tuberculosis from unnecessary extensive surgery. Serum Ca-125 level may be useful in monitoring treatment response.


Subject(s)
CA-125 Antigen/blood , Peritonitis, Tuberculous/diagnosis , Adult , Diagnosis, Differential , Female , Humans , Ovarian Neoplasms/diagnosis , Peritonitis, Tuberculous/blood
3.
J Acquir Immune Defic Syndr ; 35(2): 151-4, 2004 Feb 01.
Article in English | MEDLINE | ID: mdl-14722447

ABSTRACT

For HIV-infected women who have not received antiretroviral treatment or transmission prophylaxis in pregnancy, starting antiretrovirals in labor or soon after birth can still decrease the risk of perinatal transmission. There is, therefore, potential benefit in conducting rapid HIV testing in labor, but hospitals are seldom prepared to conduct such testing. We compared protocols for rapid HIV testing at 2 hospitals to determine what proportion of women had results back early enough to intervene if results had been positive. Hospital A initially used HIV enzyme-linked immunosorbent assays (ELISAs) and changed to using rapid tests (eg, Single Use Diagnostic System [SUDS]); hospital B used only the SUDS. With use of the SUDS in hospital A, results were reported more quickly than with the ELISA protocol in the same hospital (P < 0.0001). Comparing use of the SUDS in the 2 hospitals, test results were available more quickly in hospital A than hospital B (P < 0.05), which resulted in hospital A having more results reported prior to delivery (64% vs. 38%, P < 0.05) and within 12 hours postdelivery (94% vs. 73%, P < 0.05). If HIV testing in labor is to have its maximum effect on decreasing the risk of perinatal HIV transmission, hospitals need to institute rapid HIV testing, but protocols must ensure that results are available as quickly as possible.


Subject(s)
Acquired Immunodeficiency Syndrome/diagnosis , HIV Infections/diagnosis , HIV/isolation & purification , Obstetric Labor Complications/virology , Enzyme-Linked Immunosorbent Assay , Female , Humans , Infant, Newborn , Infectious Disease Transmission, Vertical/prevention & control , Obstetric Labor Complications/diagnosis , Postpartum Period , Pregnancy , Pregnancy Complications, Infectious/diagnosis , Pregnancy Complications, Infectious/virology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...